Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Caelyx pegylated liposomal

Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 12–13

HOS-085576 · Präparat HOS-083155

12  Hyperhidrosis Skin hyperpigmentation Uncommon Dermatitis Dermatitis exfoliative Acne Skin ulcer Dermatitis allergic Urticaria Skin discolouration Petechiae Pigmentation disorder Nail disorder Rare Toxic epidermal necrolysis Erythema multiforme Dermatitis bullous Lichenoid keratosis Not known Stevens-Johnson syndromeb Musculoskeletal and Very common Musculoskeletal pain (including connective tissue musculoskeletal chest pain, back pain, pain disorders in extremity) Common Muscle spasms Myalgia Arthralgia Bone pain Uncommon Muscular weakness Renal and urinary Common Dysuria disorders Not Known Renal-limited thrombotic microangiopathy Reproductive disorders Uncommon Breast pain Rare Vaginal infection Scrotal erythema General disorders and Very common Pyrexia administration site Fatigue conditions Common Infusion-related reaction Pain Chest pain Influenza-like illness Chills Mucosal inflammation Asthenia Malaise Oedema Oedema peripheral Uncommon Administration site extravasation Injection site reaction Face oedema Hyperthermia Rare Mucous membrane disorder Investigations Common Weight decreased Uncommon Ejection fraction decreased Rare Liver function test abnormal (including Blood bilirubin increased, Alanine aminotransferase increased and Aspartate aminotransferase increased)

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.